Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Scientific Reports|March 8, 2016
Mitochondria-targeted Triphenylamine Derivatives Activatable by Two-Photon Excitation for Triggering and Imaging Cell ApoptosisRahima Chennoufi, Houcine Bougherara, Nathalie Gagey-Eilstein, et al.Journal of Virology|June 27, 2022
Mutations in the 3'-PPT Lead to HIV-1 Replication without IntegrationClémence Richetta, Frédéric Subra, Isabelle Malet, et al.Retrovirology|March 27, 2015
Integrase inhibitor reversal dynamics indicate unintegrated HIV-1 dna initiate de novo integrationSylvain Thierry, Soundasse Munir, Eloïse Thierry, et al.The Journal of Biological Chemistry|April 2, 2011
Impairment of human immunodeficiency virus type-1 integrase SUMOylation correlates with an early replication defectAlessia Zamborlini, Audrey Coiffic, Guillaume Beauclair, et al.Scientific Reports|April 25, 2020
Interplay between Cellular Uptake, Intracellular Localization and the Cell Death Mechanism in Triphenylamine-Mediated Photoinduced Cell DeathRahima Chennoufi, Ngoc-Duong Trinh, Françoise Simon, et al.Proceedings of the National Academy of Sciences of the United States of America|July 18, 2012
Rational design of a fluorescent NADPH derivative imaging constitutive nitric-oxide synthases upon two-photon excitationYun Li, Huan Wang, Bogdan Tarus, et al.The Journal of Antimicrobial Chemotherapy|January 27, 2018
Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistanceIsabelle Malet, Francesca A Ambrosio, Frédéric Subra, et al.The Journal of Antimicrobial Chemotherapy|January 28, 2026
First characterization of insertions in the HIV-1 integrase-coding region from people with HIVNhat Quang Tu, Thomas Montrouge, Gladys Mbemba, et al.Retrovirology|November 23, 2013
Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stageErwann Le Rouzic, Damien Bonnard, Sophie Chasset, et al.Frontiers in Immunology|November 3, 2023
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infectionDéborah Lécuyer, Roberta Nardacci, Désirée Tannous, et al.Pageof 5